In January 2017, SYMBICORT 80/4.5 was approved for the treatment of asthma in patients aged six up to 12 years. SYMBICORT 80/4.5 and 160/4.5 were already approved in the US to treat asthma in ...

Symbicort is a prescription drug that’s used to treat: chronic obstructive pulmonary disease (COPD) in adults asthma in adults and certain children The active ingredients in Symbicort are ...

Symbicort (budesonide/formoterol) is a prescription drug that’s used to treat certain breathing conditions. Symbicort can cause side effects that range from mild to ...

As AstraZeneca fights to defend its aging two-drug inhaler Symbicort against generics ... approval in patients 4 and older. A first-in-class offering, Airsupra is a pressurized metered-dose ...

Viatris announced the launch of Breyna ™ (budesonide and formoterol fumarate dihydrate) inhalation aerosol, the first generic version of AstraZeneca’s Symbicort ®. Breyna is a metered-dose ...

has approved Mylan’s Abbreviated New Drug Application (ANDA) for Breyna™ (budesonide and formoterol fumarate dihydrate inhalation aerosol), the first generic version of Symbicort ...